Innovation funding

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirty-five applications for Innovation Funding of healthcare research projects were accepted. A total of 231 applications were received in response to the funding announcement of June 27, 2022 (changed on September 20, 2022), and thirty-five of them were accepted.

On April 14, 2023, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2023 RIHN list.

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirteen applications for Innovation Funding for the development or further development of the clinical guidelines. A total of 31 applications were received in response to the funding announcement of June 27, 2022, and thirteen of them were accepted.

On March 31, 2023, the Ministry of Health and Prevention published the Decree in the Official Journal of the French Republic that defines an application process for the early coverage of digital medical devices for therapeutic purposes and medical telemonitoring by health insurance.

On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program.

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023.

On February 23, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to preventing the family risk of colorectal carcinoma, shared decision-making in the hospitals, and digitally supported drug therapy management.

Surgery for rotator cuff tears has been evaluated within the "New Method" framework since 2020. In January 2023, the method assessment phase was completed, and the National Institute of Public Health (NIPH) report was published. As the recommendations from HTA are now available, the Decision Forum needs to make a coverage decision regarding the method.

On January 25, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another two completed projects. The projects relate to the improvement of the management of peripheral arterial occlusive disease (PAD) patients and the aftercare of pediatric patients suffering from chronic pain.

On January 30, 2023, the Institute for the Hospital Remuneration System (InEK) published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2022. The medical technologies belonging to the cardiovascular, eHealth, gastrointestinal, neuromodulation, neurovascular, peripheral vascular, orthopedic, and other technology groups obtained positive status 1.

On January 12, 2023, the Dutch Healthcare Institute (ZIN) will start accepting project idea applications for round 9 of the Promising Care subsidy scheme that will be awarded in 2024.

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of twenty-eight project ideas for Innovation Funding of the new forms of care within the framework of the two-stage application process. A total of 114 project ideas were received in response to the funding announcement of March 3, 2022, and only twenty-eight were accepted.